113 related articles for article (PubMed ID: 36472399)
21. Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.
Wang F; Yasuhara T; Shingo T; Kameda M; Tajiri N; Yuan WJ; Kondo A; Kadota T; Baba T; Tayra JT; Kikuchi Y; Miyoshi Y; Date I
BMC Neurosci; 2010 Apr; 11():52. PubMed ID: 20420688
[TBL] [Abstract][Full Text] [Related]
22. Melatonin preconditioning of bone marrow-derived mesenchymal stem cells promotes their engraftment and improves renal regeneration in a rat model of chronic kidney disease.
Saberi K; Pasbakhsh P; Omidi A; Borhani-Haghighi M; Nekoonam S; Omidi N; Ghasemi S; Kashani IR
J Mol Histol; 2019 Apr; 50(2):129-140. PubMed ID: 30671880
[TBL] [Abstract][Full Text] [Related]
23. Opposite effects of bone marrow-derived cells transplantation in MPTP-rat model of Parkinson's disease: a comparison study of mononuclear and mesenchymal stem cells.
Capitelli CS; Lopes CS; Alves AC; Barbiero J; Oliveira LF; da Silva VJ; Vital MA
Int J Med Sci; 2014; 11(10):1049-64. PubMed ID: 25136260
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
[TBL] [Abstract][Full Text] [Related]
25. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease.
Chen D; Fu W; Zhuang W; Lv C; Li F; Wang X
J Neurosci Res; 2017 Mar; 95(3):907-917. PubMed ID: 27617772
[TBL] [Abstract][Full Text] [Related]
27. Dissociation between dopaminergic response and motor behavior following intrastriatal, but not intravenous, transplant of bone marrow mononuclear stem cells in a mouse model of Parkinson's disease.
Calice da Silva C; Azevedo BN; Machado DC; Zimmer ER; Martins LAM; da Costa JC
Behav Brain Res; 2017 May; 324():30-40. PubMed ID: 28167338
[TBL] [Abstract][Full Text] [Related]
28. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease.
Sun Y; Lu XJ; Fu X; Zhang Y; Zhan Y; Liu J; Zhao L; Xia CL
Mol Cell Biochem; 2021 Feb; 476(2):619-631. PubMed ID: 33070275
[TBL] [Abstract][Full Text] [Related]
29. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
Jiang Z; Wang J; Sun G; Feng M
Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
[TBL] [Abstract][Full Text] [Related]
30. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
31. Bone Marrow Mesenchymal Stem Cells Reversed Ovarian Aging-related m6A RNA Methylation Modification Profile in Aged Granulosa Cells.
Tian C; An Y; Zhao J; Zhu X; Wei W; Ruan G; Li Y; Pan X
Stem Cell Rev Rep; 2023 May; 19(4):953-967. PubMed ID: 36609903
[TBL] [Abstract][Full Text] [Related]
32. Comparing neuroprotective effects of CDNF-expressing bone marrow derived mesenchymal stem cells via differing routes of administration utilizing an in vivo model of Parkinson's disease.
Jiaming M; Niu C
Neurol Sci; 2015 Feb; 36(2):281-7. PubMed ID: 25159816
[TBL] [Abstract][Full Text] [Related]
33. Human umbilical vein-derived dopaminergic-like cell transplantation with nerve growth factor ameliorates motor dysfunction in a rat model of Parkinson's disease.
Li M; Zhang SZ; Guo YW; Cai YQ; Yan ZJ; Zou Z; Jiang XD; Ke YQ; He XY; Jin ZL; Lu GH; Su DQ
Neurochem Res; 2010 Oct; 35(10):1522-9. PubMed ID: 20658188
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow-derived mesenchymal stem cell transplantation for chronic spinal cord injury in rats: comparative study between intralesional and intravenous transplantation.
Kim JW; Ha KY; Molon JN; Kim YH
Spine (Phila Pa 1976); 2013 Aug; 38(17):E1065-74. PubMed ID: 23629485
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic effect of integrin-linked kinase gene-modified bone marrow-derived mesenchymal stem cells for streptozotocin-induced diabetic cystopathy in a rat model.
Huang Y; Gao J; Zhou Y; Wu S; Shao Y; Xue H; Shen B; Ding L; Wei Z
Stem Cell Res Ther; 2020 Jul; 11(1):278. PubMed ID: 32650831
[TBL] [Abstract][Full Text] [Related]
36. Stem cell therapy ameliorates bladder dysfunction in an animal model of Parkinson disease.
Soler R; Füllhase C; Hanson A; Campeau L; Santos C; Andersson KE
J Urol; 2012 Apr; 187(4):1491-7. PubMed ID: 22341818
[TBL] [Abstract][Full Text] [Related]
37. Enhanced neuroprotective efficacy of bone marrow mesenchymal stem cells co-overexpressing BDNF and VEGF in a rat model of cardiac arrest-induced global cerebral ischemia.
Zhou L; Lin Q; Wang P; Yao L; Leong K; Tan Z; Huang Z
Cell Death Dis; 2017 May; 8(5):e2774. PubMed ID: 28492549
[TBL] [Abstract][Full Text] [Related]
38. Age-related gene expression changes in substantia nigra dopamine neurons of the rat.
Parkinson GM; Dayas CV; Smith DW
Mech Ageing Dev; 2015 Jul; 149():41-9. PubMed ID: 26065381
[TBL] [Abstract][Full Text] [Related]
39. Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases.
Sadan O; Shemesh N; Cohen Y; Melamed E; Offen D
Isr Med Assoc J; 2009 Apr; 11(4):201-4. PubMed ID: 19603590
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction.
Flynn A; Chen X; O'Connell E; O'Brien T
Stem Cell Res Ther; 2012 Sep; 3(5):36. PubMed ID: 22974654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
